In Australia, Collagen Solutions PLC, which is registered in London and has global headquarters in Minnesota, received additional patent protection. The patent allows Collagen to source animal-based biomaterials from Australia for their pericardium tissue for heart valve replacements, orthopedics, dental industry, wound healing, surgery, and other medical uses. Australia and New Zealand are often sought-after by companies looking for high quality animal-based biomaterials because they have strict controls and have been doing it for a long time. Collagen’s CEO, Jamal Rushdy, told Proactive Investors UK, “This recent patent further strengthens our position in sourcing tissue in Australia in a novel way. We believe the additional processing covered in this patent will be of significant interest to our existing customer base.”
Latest article
Dutch Queen promotes biobased building materials
In the Netherlands, Dutch Queen consort Máxima visited two Uden worksites promoting biobased building materials made from Netherlands fiber crops.
The March 26 visit...
ReefCircular launches crowdfunding campaign for shell bioconcrete
In Denmark, ReefCircular, a company developing a shell-based bioconcrete to help restore marine habitats, has launched a crowdfunding campaign on Kickstarter.
The company’s bioconcrete...
Aleph Farms raises $29 million for lab-grown steak
In Israel, cultivated meat producer Aleph Farms has raised $29 million to expand production at its Rehovot pilot plant and expand production into Europe...